Some common side effects may include but are not limited to mild irritation at the injection site
In summary, Se deficiency appears to be a risk factor for HT and the current evidence does not justify the use of Se supplementation as part of the treatment of HT, despite its ability to improve immune function
With Cyanocobalamin (vitamin B12) as the active component, the supplement helps recover from vitamin B12 deficiencies and treat macrocytic anaemia
Rights and permissions Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s)
No evidence of hormonal, hepatic, or systemic adverse effects has been observed in available preclinical data
Legal Status in Germany and the EU Regulatory Classification BPC-157 is not approved by the European Medicines Agency (EMA) and cannot be prescribed as a pharmaceutical in Germany, the EU, or most other developed countries